haem synthesis or during haem catabolism. The presence of free base protoporphyrin in plasma is usually a consequence of aberrant haem biosynthesis. Although drug-induced protoporphyria is rarely observed in man, high doses of griseofulvin cause an hepatic protoporphyria in laboratory animals which results in elevated concentrations of plasma and erythrocyte free protoporphyrin (PohFitzpatrick & Lamola, 1977) and increased levels of plasma haemopexin (Cripps et al., 1977) . In man, lead poisoning usually leads to the accumulation of zinc protoporphyrin in erythrocytes (Lamola & Yamane, 1974) . Significantly abnormal concentrations of metal-free protoporphyrin are observed only in severe acute cases. However, in such cases only the metal-free protoporphyrin is ever found in plasma (Lamola & Yamane, 1974; PohFitzpatrick & Lamola, 1976) .
Congenital human protoporphyria is a wellrecognized disease in which both the erythropoietic and hepatic tissues may be sites of excess porphyrin synthesis (Lamon et al., 1980) . Whenever liver function is unimpaired, plasma protoporphyrin is cleared rapidly and a flow of excess protoporphyrin from the erythrocytes to the plasma is maintained.
Efficient hepatic clearance appears to be crucial for maintenance of a low concentration of porphyrin in the skin (Lamon et al., 1980) , thereby controlling concomitant photosensitivity. The fatal liver failure which occurs in protoporphyria may be the result of the continuous hepatic clearance of protoporphyrin (Lamon et al., 1980) . It is therefore important to 0306-3283/81/060693-06$01.50/1 (© 1981 The Biochemical Society define clearly the mechanisms of transport and excretion of protoporphyrin.
Clearance ofprotoporphyrin
In patients with protoporphyria, the rate of protoporphyrin excretion into the bile has been reported to be as high as 50mg/day (Lamon et al., 1980 ). It appears that protoporphyrin is, for the most part, excreted unchanged, and that very little is catabolized (Ibrahim et al., 1966; Ibrahim & Watson, 1968) . This is unlike haem, which is in great part rapidly catabolized in the liver, and unlike bilirubin, which is esterified in the liver and excreted in conjugated form (Schmid & McDonagh, 1978) .
The concentration of protoporphyrin in plasma of patients with uncomplicated protoporphyria is of the order of 1 pm. This concentration is smaller than those of either haemopexin (about 5-1O0uM) or albumin (about 500pM). Concentrations of haemopexin and turnover time for this plasma protein in these patients do not appear to differ significantly from the normal range of values. Gel-filtration chromatography and electrophoretic fractionation of normal plasma to which protoporphyrin is added reveals that most of the porphyrin is associated with fractions containing albumin and haemopexin (Koskelo et al., 1970) . The fluorescence emission and excitation spectra of plasma specimens from patients with protoporphyria are identical with those of protoporphyrin bound to albumin. Although these observations and the binding studies of Seery & Muller-Eberhard (1973) suggest that protoporphyrin in the plasma of patients with protoporphyria is chiefly bound to albumin, binding of a significant fraction of the protoporphyrin to haemopexin and a role for haemopexin in the clearance of protoporphyrin cannot be excluded. Metabolic studies of haemopexin (Wochner et al., 1974; Muller-Eberhard et al., 1974) in patients with protoporphyria left uncertain the involvement of this protein in the disposal of protoporphyrin. We therefore undertook to assess further in vitro the relative roles of human albumin and haemopexin in protoporphyrin binding. We characterized the haemopexin-protoporphyrin complex spectroscopically and determined the affinities of haemopexin and albumin for protoporphyrin.
Experimental Preparation ofmaterials
Protoporphyrin (>90%) (Porphyrin Products, Logan, UT, U.S.A.) was used as received. A few crystals were dissolved in a small volume (5,u1) of concentrated ammonia. The resulting solution was diluted with 20ml of buffered saline (0.15M-NaCl/0.0 I M-sodium phosphate, pH 7.4), left at 40C for 1 h, and filtered through paper (Whatman no. 1).
The concentration of protoporphyrin was determined by measuring the A406 of a sample made 2.4 M in HCI by using gnlM = 242. The solution (usually about 10pUM) was then diluted with buffered saline to make stock solutions of concentrations 0.1-1 uM. Protoporhyrin solutions were stored at 40C shielded from light and used within a few hours of preparation.
Human serum albumin was prepared from the plasma of adult male volunteers by a variation (Lamola et al., 1979) of the method of Flodin & Killander (1962) and stored at pH3 and 40C. The protein was used within 5 days of its preparation. Its purity was assayed by the Bromocresol Green colorimetric method (Doumas et al., 1971) , by A280 measurement by using E= 36 000, and fluorimetrically by using bilirubin binding (Lamola et al., 1979) . Only preparations assayed to be over 90% pure by all three methods were used.
Haemopexin was prepared from plasma by the method described by Hrkal & Muller-Eberhard (1971) . Freeze-dried specimens, stored at -200C, were dissolved in buffered saline and used immediately. Haemopexin was assayed by measuring the A280 by using Al%m = 20 (Seery et al., 1972) .
Fluorescence spectroscopy
Fluorimetric measurements were made with a Perkin-Elmer MPF4 spectrofluorimeter. A cut-off filter (Hoya 0-56) was used to decrease scattered excitation light for specimens with low fluorescence signals.
Results

Fluorescence of protoporphyrin in diferent microenvironments
The fluorescence emission and excitation maxima of protoporphyrin as well as its fluorescence quantum yield vary with its microenvironment. Representative emission spectra of protoporphyrin in the presence and absence of protein are shown in Fig. 1 . Lists of the wavelengths of the maxima of the most intense (0-0) band of the fluorescence spectra, the maxima of the Soret bands of the fluorescence excitation spectra and some relative fluorescence yields are given in Table 1 . The data refer to specimens in buffered saline (pH 7.4) containing concentrations of proteins sufficient to ensure that virtually all the protoporphyrin (0.1 pM) was bound to the strongest protein-binding site.
Affinitv of protoporplvrin for serum albumin and haemopexin
The spectra of Fig. 1 show that the binding of protoporphyrin to albumin can be well monitored by the increase in intensity at 635 nm durijng titration of protoporphyrin in buffered saline with albumin.
Such fluorimetric titrations were carried out at protoporphyrin concentrations (1-10nM) at which binding at the strongest albumin site(s) could be observed. Typical data are shown in Fig. 2 ; 17 independent titrations were performed, with three different preparations of albumin. In all the experiments an excellent fit (see Fig. 2 Weaker secondary sites for binding of protoporphyrin and albumin were observed fluorimetrically at much higher porphyrin and protein concentrations than those necessary to observe primary binding. Since plasma protoporphyrin concentrations observed even in the most severe cases of protoporphyria do not approach the albumin concentration, these secondary sites were not further investigated.
The affinity of haemopexin for protoporphyrin was determined relative to that of albumin. Both the quantum yield and the fluorescence maximum of the haemopexin complex differ from those of the albumin-protoporphyrin complex (Fig. 1) . Thus, at constant protoporphyrin concentration and combined concentrations of the proteins that ensure binding of all the porphyrin, the ratio of protoporphyrin bound to albumin to that bound to haemopexin can be obtained directly by comparing fluorescence spectra from mixtures of the two proteins with spectra in the presence of each alone. Spectra from such a competition experiment are shown in Fig. 3 . The reference spectra for this experiment are shown in Fig. 1 M 1 (250C).
Protoporphyin in plasma
The fluorescence spectrum of human plasma to which was added 0.3,uM-protoporphyrin was identical with that of plasma from patients with protoporphyria (Fig. 4) . The intensities of the fluorescences were approximately in proportion to the protoporphyrin concentrations in the specimens as determined by extraction methods (PohFitzpatrick et al., 1973) . Spectra from the native and synthetic protoporphyrin-plasma complexes were The observations that the fluorescence spectra of protoporphyrin added to normal plasma, of plasma from patients with protoporphyria and of the albumin-protoporphyrin complex are the same within experimental certainty are verified. The fluorescence emission spectrum of haemopexinprotoporphyrin was found to be shifted from that of the albumin-protoporphyrin complex by 6nm. This shift is sufficient to support the conclusion that only a small fraction, 10% at most, of the protoporphyrin in plasma could be bound to haemopexin. Further quantification of this conclusion can be obtained from the relative association constants. Both binding strength and concentration favour binding of protoporphyrin by albumin over that by haemopexin. The ratios for these are 4 and 50-100 respectively, indicating that the ratio of protoporphyrin bound to albumin to that bound to haemopexin in plasma is 200-400, i.e. less than 0.5% of the protoporphyrin in plasma is bound to haemopexin. Our results settle a disagreement which has existed in the literature between results of Koskelo et al. (1970) , who suggested that protoporphyrin is mostly bound to albumin in plasma, and Marecek et al. (1973) , who suggested that protoporphyrin is mostly bound to haemopexin. Neither groups employed methods that could assess the relative affinity constants for the first protoporphyrin bound to each of the proteins. Because of the necessity to use very low concentrations of protoporphyrin and albumin, the fluorimetric titration method that we employed appears to be the best approach presently available for accurate determination of the binding constants. Furthermore, the fluorescence method has allowed direct competition experiments without the necessity to separate the proteins. Implicationsfor protoporphyrin clearance
The very high value for the association constant of the albumin-protoporphyrin complex, 3 x 109M-1, predicts that, for the concentrations of protoporphyrin and albumin found in the typical patient with protoporphyria, the concentration of unbound plasma protoporphyrin is of the order of 0.001 nM. It is interesting to compare this exceedingly low concentration of unbound protoporphyrin and the apparent 50,umol of protoporphyrin/day cleared through the liver of a patient with protoporphyria with the situation for bilirubin clearance. Unconjugated bilirubin, which is taken up by the liver at a rate of the order of 500,umol/day, normally presents an unbound concentration in the plasma of the order of 1 nM (Schmid & McDonagh, 1978) , i.e. the unbound bilirubin concentration is 1000 times higher than the unbound protoporphyrin concentration, whereas the uptake rates differ perhaps by only a factor of 10. If hepatocytes take up both tetrapyrroles only in unbound form, the specific rate of uptake of protoporphyrin would have to be very much higher than that for bilirubin. Alternatively, the relatively rapid uptake of plasma protoporphyrin by the liver in the face of an extremely low unbound protoporphyrin concentration may involve a carrier protein. 
